Cell sensitivity to transplacental mutagenesis by N-ethyl-N-nitrosourea is greatest during early gestation in the Syrian hamster

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 427, Issue 1, 1999, Pages 53-64

  Donovan, Paul J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

6 Thioguanine; Diphtheria toxin; Embryo; Fetus; Mutation; N ethyl N nitrosourea

Indexed keywords

DIPHTHERIA TOXIN; ETHYLNITROSOUREA; TIOGUANINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FETUS; GENOTOXICITY; MUTAGENESIS; MUTATION RATE; NIDATION; NONHUMAN; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; RISK; SYRIAN HAMSTER; TRANSPLACENTAL CARCINOGENESIS;

EID: 0033151419     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00085-8     Document Type: Article

References (14)

1. S. Ivankovic, H. Druckrey, Transplacentare erzeugung maligner tumoren des nervensystem: I. Äthyl-nitroso-harnstoff (ÄNH) an BD IX-ratten, Z. Krebsforsch. 71 (1968) 320-360.
2. T. Shibuya, K. Morimoto, A review of the genotoxicity of 1-ethyl-1-nitrosourea, Mutat. Res. 297 (1993) 3-38.
3. H. Bartsch, L. Malaveille, L. Tomatis, G. Brun, B. Dodet, B. Terracini, Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents, IARC Sci. Publ. 41 (1982) 525-532.
4. J.M. Rice, Transplacental carcinogenesis in mice by 1-ethyl-1-nitrosourea, Ann. NY Acad. Sci. 163 (1969) 813-827.
5. B.A. Diwan, S. Rehm, J.M. Rice, Age- And dose-dependent transplacental carcinogenesis by N-nitrosoethylurea in syrian golden hamsters, J. Cancer Res. Clin. Oncol. 122 (1996) 643-652.
6. P. Kleihues, M.F. Rajewsky, Chemical neuro-oncogenesis: Role of structural DNA modifications, DNA repair and neural target cell population. Prog. Exp. Tumor Res. 27 (1984) 1-16.
7. 6-ethylguanine from the DNA of brain, liver, and other rat tissues exposed to ethylnitrosourea at different stages of prenatal development, Cancer Res. 43 (1983) 2897-2904.
8. P.J. Donovan, G.T. Smith, Cell sensitivity to transplacental mutagenesis by N-ethyl-N-nitrosourea is greatest during early gestation in the Syrian hamster. Mutat. Res. 427 (1999) 53-64, (this issue).
9. E. Cayama, H. Tsuda, D.S.R. Sarma, E. Farber, Initiation of chemical carcinogenesis requires cell proliferation, Nature 275 (1978) 60-62.
10. W.K. Kaufmann, D.G. Kaufman, J.M. Rice. M.L. Wenk, Reversible inhibition of rat hepatocyte proliferation by hydrocortisone and its effect on cell cycle-dependent hepatocarcinogenesis by N-methyl-N-nitrosourea, Cancer Res. 41 (1981) 4653-4660.
11. W. Wechsler, J.M. Rice, S.D. Vesselinovitch, Transplacental and neonatal induction of neurogenic tumors in mice: Comparison with related species and with human pediatric neoplasms, Natl. Cancer Inst. Monogr. 51 (1979) 219-226.
12. D. Stavrou. E. Dahme, T. Haenichen, Transplacental carcinogenesis in the rabbit, In: H.M. Schuller (Ed.), Comparative Perinatal Carcinogenesis, CRC Press, Boca Raton, FL, 1984, pp. 23-43.
13. J.M. Rice, S. Rhem, P.J. Donovan, A.O. Perantoni, Comparative transplacental carcinogenesis by directly acting and metabolism-dependent alkylating agents in rodents and non- Human primates, IARC Sci. Publ. 96 (1989) 17-34.
14. K. Goerttler, H. Loehrke, B. Hesse, A. Milz, J. Schweizer, Diaplacental initiation of NMRI mice with 7,12-dimethyl- Benz[a]anthracene during gestation days 6-20 and postnatal treatment of the F1-generation with the phorbol ester 12-0- Tetradecanoylphorbol-13-acetate: Tumor incidence in organs other than skin, Carcinogenesis 2 (1981) 1087-1094.